Accelerating Adoption of Patient-centered Cervical Cancer Screening and Treatment Linkage in Kenya

NANot yet recruitingINTERVENTIONAL
Enrollment

1,980

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Cervical CancerCervical Cancer ScreeningHPV DNA
Interventions
BEHAVIORAL

DADA LINK

"Intervention facilities will receive the DADA-LINK intervention, comprised of:~1. HPV self-sampling: We will provide clinics with HPV self-sampling kits to administer to eligible patients.~2. Care Navigation: One study-supported non-physician care navigator will be assigned to each clinic to support the clinic staff. These trained individuals will be responsible for managing data collection through the mHealth platform to aid the coordination of services and for motivating the clinic staff to adhere to cervical cancer care guidelines.~3. mHealth support for cervical cancer screening and treatment linkage: The WEMA application is a low-cost and highly adaptable open-source application designed for cervical cancer data monitoring and evaluation. Relevant patient information and data on uptake of cervical cancer screening and triage/treatment will be entered in the WEMA platform. The platform will additionally be used to send text messages to patients to facilitate clinic attendance."

Trial Locations (1)

Unknown

Kenyatta National Hospital, Nairobi

All Listed Sponsors
collaborator

Emory University

OTHER

collaborator

University of Washington

OTHER

collaborator

National Cancer Institute (NCI)

NIH

collaborator

Kenya Ministry of Health

OTHER_GOV

collaborator

Queen's University

OTHER

collaborator

University of Nairobi

OTHER

lead

Kenyatta National Hospital

OTHER_GOV